PULSE BIOSCIENCES, INC. (PLSE)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | - | - | - | - |
| Research and development | 12,088 | 10,313 | 7,703 | 7,230 |
| General and administrative | 8,187 | 7,731 | 5,952 | 4,496 |
| Total cost and expenses | 20,275 | 18,044 | 13,655 | 11,726 |
| Loss from operations | -20,275 | -18,044 | -13,655 | -11,726 |
| Interest income, net | 1,107 | 1,249 | 975 | 343 |
| Total other income | 1,107 | 1,249 | 975 | 343 |
| Loss from operations, before income taxes | -19,168 | -16,795 | -12,680 | -11,383 |
| Income tax benefit | - | - | - | - |
| Net loss | -19,168 | -16,795 | -12,680 | -11,383 |
| Comprehensive loss | -19,168 | -16,795 | -12,680 | -11,383 |
| Basic and diluted net loss per share (in dollars per share) | -0.28 | -0.25 | -0.21 | -0.2 |
| Weighted average shares used to compute net loss per common share basic and diluted (in shares) | 67,276,000 | 67,126,000 | 61,066,000 | 57,180,000 |